Compile Data Set for Download or QSAR
Report error Found 1917 Enz. Inhib. hit(s) with all data for entry = 10535
TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546867((S)-3-((S)-6-(methoxycarbonyl)-7-methyl-3-(tetrahy...)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546868(US11292791, Example 141)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546870(US11292791, Example 143)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547115(US11292791, Example 388)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547116(US11292791, Example 389)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547119(US11292791, Example 392)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546882(US11292791, Example 155)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547139(US11292791, Example 412)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547140((1R,3R)-3-[(7S)-2-[(R)-(4-chlorophenyl)(hydroxy)me...)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547141(US11292791, Example 415 | US11292791, Example 414)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546885(US11292791, Example 158)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547141(US11292791, Example 415 | US11292791, Example 414)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547143(US11292791, Example 437 | US11292791, Example 416)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546887(US11292791, Example 160)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547144(US11292791, Example 418 | US11292791, Example 417)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546888(US11292791, Example 161)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547144(US11292791, Example 418 | US11292791, Example 417)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547146(US11292791, Example 460 | US11292791, Example 419)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547131(US11292791, Example 475 | US11292791, Example 791 ...)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547132(US11292791, Example 720 | US11292791, Example 405)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547133(US11292791, Example 763 | US11292791, Example 406)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547134(US11292791, Example 783 | US11292791, Example 845 ...)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547135(US11292791, Example 408)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547136(US11292791, Example 409)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547137(US11292791, Example 410)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547138(US11292791, Example 411)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546898(US11292791, Example 171)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547155(US11292791, Example 638 | US11292791, Example 428)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547156(US11292791, Example 429)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546900(US11292791, Example 173)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547157(US11292791, Example 431 | US11292791, Example 430)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547157(US11292791, Example 431 | US11292791, Example 430)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546902(US11292791, Example 175)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547159(US11292791, Example 479 | US11292791, Example 432)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546903(US11292791, Example 176)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547148(US11292791, Example 433 | US11292791, Example 421)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547161(US11292791, Example 448 | US11292791, Example 434)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546905(US11292791, Example 178)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547162(US11292791, Example 435)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546890(US11292791, Example 163)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547147(US11292791, Example 438 | US11292791, Example 420)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546891(US11292791, Example 164)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547148(US11292791, Example 433 | US11292791, Example 421)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547149(US11292791, Example 422)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547150(US11292791, Example 523 | US11292791, Example 423)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546894(US11292791, Example 167)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547151(US11292791, Example 660 | Intermediate 2-(5-fluoro...)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547152(US11292791, Example 545 | US11292791, Example 425)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM546896(US11292791, Example 169)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

TargetCREB-binding protein(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM547153(US11292791, Example 461 | US11292791, Example 426)
Affinity DataIC50: 5.5nMAssay Description:The assay was performed in a final volume of 6 μL in assay buffer containing 50 mM Hepes (pH 7.5, (0.5M Hepes, pH 7.5 solution; Teknova H1575)),...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
US Patent

Displayed 1 to 50 (of 1917 total ) | Next | Last >>
Jump to: